These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1085157)

  • 1. [Abnormal formation of rosette (E and EAC) in Hodgkin's disease].
    Lenzini L; Rottoli L; Rottoli P
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1579-83. PubMed ID: 1085157
    [No Abstract]   [Full Text] [Related]  

  • 2. T and B spleen lymphocytes in Hodgkin's disease.
    Santoro A; Belpomme D; Mathe G
    Haematologica; 1977 Feb; 62(1):11-22. PubMed ID: 404218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosette-forming lymphocytes in Hodgkin's disease.
    Cohnen G; Augener W; Brittinger G; Douglas SD
    N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 8. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T- and B-lymphocyte changes in lymphogranulomatosis].
    Il'in NV; Vinokurova NA; Gershanovich ML; Letskiĭ VB
    Vopr Onkol; 1979; 25(6):19-22. PubMed ID: 380155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of T-cell dependent humoral & cell-mediated immune responses by sera of Hodgkin's disease patients.
    Tuteja N; Natu SM; Gupta AK; Kapoor AK; Mehrotra RM; Kumar A
    Indian J Med Res; 1983 Jul; 78 Suppl():81-7. PubMed ID: 6606623
    [No Abstract]   [Full Text] [Related]  

  • 13. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of thymus-dependent and bursa-dependent lymphocytes (T and B) in some lymphoproliferative diseases].
    Barabino A; Di Benedetto G; Franceschini R; Indiveri F; Puppo F; Soldà AM
    Boll Soc Ital Biol Sper; 1975 Nov; 51(22):1612-6. PubMed ID: 1084753
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosette formation in Hodgkin's disease.
    Swain A; Trounce JR
    Oncology; 1974; 30(6):449-57. PubMed ID: 4549695
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 18. [Peripheral blood lymphocyte subpopulations in Hodgkin's disease].
    Burchardt K
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1283-5. PubMed ID: 1080566
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B; Biniaminov M; Shoham C; Rosenthal E
    N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.